Company page

Cardiol Therapeutics Inc. Class A

Cardiol Therapeutics Inc. Class A (ticker: CRDL) is a public company based in Canada, with a market capitalization of approximately CAD 122.3 million. The company focuses on developing innovative therapies for heart diseases. Its research and development efforts aim to address significant unmet medical needs in cardiovascular health.